Our Mission: To develop drug therapies for preventing and treating cognitive impairment and pain caused by inflammation.
Brain Inflammation: Pain, cognitive impairment and memory loss associated with brain inflammation
• Major causes of serious health problems
• Highly comorbid with diseases such as heart disease, diabetes, arthritis, cancer and trauma
• Decreased quality of life and their ability to care for themselves and maintain independence
• Major stress and secondary financial impacts on family members
• Significant societal costs due to cost of care and lost work productivity
Company: ProNeurogen is an early-stage biotech company founded in 2013 out of the University of Arizona.
•Exclusive licensee of the technology
•Protected by strong intellectual property including 3 patents issued in 2017.
•Game-changing, first-in-class and disruptive technologies.